🇰🇷 Sparcin in South Korea

Sparcin (SPARFLOXACIN) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Sparcin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in South Korea

Frequently asked questions

Is Sparcin approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Sparcin in South Korea?

Marketing authorisation holder not available in our data.